跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
希瑞适 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Human Papillomavirus (Types 16,18) Vaccine, Adsorbed
Approved
生物制品
Human Papillomavirus (Types 16,18) Vaccine, Adsorbed
GlaxoSmithKline Biologicals SA
🇨🇳 National Medical Products Administration
Approval Date
Aug 10, 2021
Approval ID
8BYsPBZauey
Company
GlaxoSmithKline Biologicals SA
Type
生物制品
Approval Details
Approval Id
8BYsPBZauey
Approval Number
国药准字SJ20160025
Generic Name
双价人乳头瘤病毒吸附疫苗
Generic Name En
Human Papillomavirus (Types 16,18) Vaccine, Adsorbed
Trade Name
希瑞适
Drug Type
生物制品
Dosage Form
注射剂
Strength
0.5ml/支(含HPV-16 L1蛋白和HPV-18 L1蛋白各20μg)
Reg Date
2021-08-10
Expired Date
2026-08-09
Company Name
GlaxoSmithKline Biologicals SA
Production Company Name
GlaxoSmithKline Biologicals SA
Company Detail Path
/organization/glaxosmithkline-biologicals-sa
Production Company Detail Path
/organization/glaxosmithkline-biologicals-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 10, 2021
Approval ID
8BYsPBZauey
Type
生物制品
Back to NMPA Approvals